Ellen M.N. Bannink

588 total citations
14 papers, 427 citations indexed

About

Ellen M.N. Bannink is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Ellen M.N. Bannink has authored 14 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Genetics. Recurrent topics in Ellen M.N. Bannink's work include Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (7 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Birth, Development, and Health (6 papers). Ellen M.N. Bannink is often cited by papers focused on Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (7 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Birth, Development, and Health (6 papers). Ellen M.N. Bannink collaborates with scholars based in Netherlands, United States and Denmark. Ellen M.N. Bannink's co-authors include Paul Mulder, Sabine M.P.F. de Muinck Keizer‐Schrama, Anita C. S. Hokken‐Koelega, Hein Raat, Yvonne K. van Pareren, Marije van Dijk, Roel L.F. van der Palen, Stef van Buuren, Anita Hokken-Koelega and Frank H. de Jong and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The American Journal of Cardiology and The Journal of Pediatrics.

In The Last Decade

Ellen M.N. Bannink

14 papers receiving 416 citations

Peers

Ellen M.N. Bannink
J.M. Limal France
W. Rosendahl Germany
Judd Hl United States
W Hoepffner Germany
Cristin C. Slater United States
Ellen M.N. Bannink
Citations per year, relative to Ellen M.N. Bannink Ellen M.N. Bannink (= 1×) peers Yvonne K. van Pareren

Countries citing papers authored by Ellen M.N. Bannink

Since Specialization
Citations

This map shows the geographic impact of Ellen M.N. Bannink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen M.N. Bannink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen M.N. Bannink more than expected).

Fields of papers citing papers by Ellen M.N. Bannink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen M.N. Bannink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen M.N. Bannink. The network helps show where Ellen M.N. Bannink may publish in the future.

Co-authorship network of co-authors of Ellen M.N. Bannink

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen M.N. Bannink. A scholar is included among the top collaborators of Ellen M.N. Bannink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen M.N. Bannink. Ellen M.N. Bannink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Plötz, Frans B., et al.. (2024). Adherence to Dutch Guideline in Hospitalized Anorexia Nervosa Adolescents. Global Pediatric Health. 11. 2333794X231221931–2333794X231221931. 1 indexed citations
3.
Bannink, Ellen M.N., et al.. (2010). Adult height and health-related quality of life after growth hormone therapy in small for gestational age subjects. Journal of Medical Economics. 13(2). 221–227. 16 indexed citations
4.
Bannink, Ellen M.N., Roel L.F. van der Palen, Paul Mulder, & Sabine M.P.F. de Muinck Keizer‐Schrama. (2009). Long-Term Follow-Up of GH-Treated Girls with Turner Syndrome: Metabolic Consequences. Hormone Research in Paediatrics. 71(6). 343–349. 32 indexed citations
5.
Bannink, Ellen M.N., Roel L.F. van der Palen, Paul Mulder, & Sabine M.P.F. de Muinck Keizer‐Schrama. (2009). Long-Term Follow-Up of GH-Treated Girls with Turner Syndrome: BMI, Blood Pressure, Body Proportions. Hormone Research in Paediatrics. 71(6). 336–342. 27 indexed citations
6.
Bannink, Ellen M.N., Stef van Buuren, Frank H. de Jong, et al.. (2008). Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels. Clinical Endocrinology. 70(2). 265–273. 58 indexed citations
7.
Berg, Jochem van den, Ellen M.N. Bannink, Piotr A. Wielopolski, et al.. (2008). Cardiac Status after Childhood Growth Hormone Treatment of Turner Syndrome. The Journal of Clinical Endocrinology & Metabolism. 93(7). 2553–2558. 13 indexed citations
8.
Ester, Wietske A., Ellen M.N. Bannink, Marije van Dijk, et al.. (2007). Subclassification of Small for Gestational Age Children with Persistent Short Stature: Growth Patterns and Response to GH Treatment. Hormone Research in Paediatrics. 69(2). 89–98. 17 indexed citations
9.
Bannink, Ellen M.N., Jaap van Doorn, Paul Mulder, & Anita Hokken-Koelega. (2007). Free/Dissociable Insulin-Like Growth Factor (IGF)-I, Not Total IGF-I, Correlates with Growth Response during Growth Hormone Treatment in Children Born Small for Gestational Age. The Journal of Clinical Endocrinology & Metabolism. 92(8). 2992–3000. 20 indexed citations
10.
Berg, Jochem van den, Ellen M.N. Bannink, Piotr A. Wielopolski, et al.. (2006). Aortic Distensibility and Dimensions and the Effects of Growth Hormone Treatment in the Turner Syndrome. The American Journal of Cardiology. 97(11). 1644–1649. 35 indexed citations
11.
Bannink, Ellen M.N., Hein Raat, Paul Mulder, & Sabine M.P.F. de Muinck Keizer‐Schrama. (2006). Quality of Life after Growth Hormone Therapy and Induced Puberty in Women with Turner Syndrome. The Journal of Pediatrics. 148(1). 95–101. 65 indexed citations
12.
Bannink, Ellen M.N., Jaap van Doorn, Theo Stijnen, Stenvert L. S. Drop, & Sabine M.P.F. de Muinck Keizer‐Schrama. (2006). Free dissociable insulin‐like growth factor I (IGF‐I), total IGF‐I and their binding proteins in girls with Turner syndrome during long‐term growth hormone treatment. Clinical Endocrinology. 65(3). 310–319. 12 indexed citations
13.
Dijk, Marije van, Ellen M.N. Bannink, Yvonne K. van Pareren, Paul Mulder, & Anita C. S. Hokken‐Koelega. (2006). Risk Factors for Diabetes Mellitus Type 2 and Metabolic Syndrome Are Comparable for Previously Growth Hormone-Treated Young Adults Born Small for Gestational Age (SGA) and Untreated Short SGA Controls. The Journal of Clinical Endocrinology & Metabolism. 92(1). 160–165. 75 indexed citations
14.
Bannink, Ellen M.N., et al.. (2005). Quality of Life in Adolescents Born Small for Gestational Age: Does Growth Hormone Make a Difference?. Hormone Research in Paediatrics. 64(4). 166–174. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026